China Medical & HealthCare Group Limited
COLRF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -1.42 | -0.00 | 0.00 | -0.02 |
| FCF Yield | -1.66% | 0.00% | -12,410.89% | 12.22% |
| EV / EBITDA | 54.45 | -0.61 | 0.11 | 6.73 |
| Quality | ||||
| ROIC | 1.19% | 1.04% | 1.41% | 1.17% |
| Gross Margin | 19.15% | 18.73% | 21.13% | 14.86% |
| Cash Conversion Ratio | -0.35 | – | -0.54 | 18.23 |
| Growth | ||||
| Revenue 3-Year CAGR | 8.44% | 9.48% | 11.67% | 9.02% |
| Free Cash Flow Growth | 0.00% | 100.00% | -212.88% | 39.11% |
| Safety | ||||
| Net Debt / EBITDA | 4.08 | -0.62 | 0.10 | -0.92 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 2.52 |
| Efficiency | ||||
| Inventory Turnover | 2.33 | 2.27 | 2.28 | 2.33 |
| Cash Conversion Cycle | 35.43 | 33.74 | 30.69 | 18.99 |